期刊文献+

十二指肠间质瘤46例临床诊治分析 被引量:8

Duodenal gastrointestinal stromal tumors: diagnosis and treatment of 46 cases
原文传递
导出
摘要 目的:分析十二指肠间质瘤的临床特点、诊断方法和手术治疗方式,探讨患者各临床因素与术后生存期的关系。方法:回顾性分析中南大学湘雅医院11年间诊治的46例十二指肠间质瘤患者的临床资料。结果:患者以上消化道出血、腹部胀痛不适为主要症状。发病部位以降部多见。行局部切除(LE)22例,16例行节段性十二指肠切除术(SD),行胰十二指肠切除术(PD)6例,2例患者放弃治疗(1例死亡,1例失访)。术后随访44例,28例生存,6例死亡,10例失访。4例出现术后并发症,其中1例为LE术后并发十二指肠瘘,经非手术治疗痊愈出院,3例为PD术后胰瘘(1例死于术后胰瘘出血性休克,2例经非手术治疗痊愈出院)。患者术后平均生存期为(35.4±28.7)个月,术后生存期在性别、年龄、肿瘤大小、肿瘤复发风险分级、肿瘤发生部位及手术方式各组间差异无统计学意义(均P>0.05)。结论:CT、消化道内镜及超声内镜检查是术前诊断十二指肠间质瘤的主要手段,完整切除是该病基本手术方式,术后生存期在性别、年龄、肿瘤大小、肿瘤复发风险分级、肿瘤发生部位及手术方式等无关。 Objective: To investigate the clinical characteristics, diagnostic method and surgical procedures of duodenal gastrointestinal stromal tumors (DGISTs), and the relations of postoperative survival with various clinical factors. Methods: The clinical data of 46 DGIST patients admitted in Xiangya Hospital over the past 11 years were retrospectively analyzed.Results: Among the DGIST patients, the major symptoms were upper alimentary tract hemorrhage and abdominal distending pain or discomfort, and the most commonly involved region was the descending part of the duodenum. Twenty-two patients received local tumor excision (LE), 16 patients underwent segmental duodenectomy (SD), 6 patients were subjected to pancreaticoduodenectomy (PD), and two patients refused operative treatment (one died and one was lost to follow-up). Forty-four patients were followed up after surgery, at which time, 28 cases had survived, 6 cases and died, and 10 cases were lost to follow-up. Postoperative complications occurred in 4 patients; one of them developed duodenal fistula after LE and recovered after conservative treatment, and three cases developed pancreatic fistula following PD, of whom, one died of hemorrhagic shock and the other two recovered after conservative treatment. The mean survival time was (35.4~28.7) months, and the differences in postoperative survival among the groups divided according to gender, age, tumor size, tumor recurrence risk classification, tumor location and surgical procedures showed no statistical significance (aU P〉0.0S). Conclusion: C% endoscopy and ultrasound endoscopy are the main approaches for preoperative diagnosis of DGISTs. Complete resection is the primary treatment for this condition and the postoperative survival is not associated with gender, age, tumor size, tumor recurrence risk classification, tumor location or surgical procedures.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2013年第10期1324-1328,共5页 China Journal of General Surgery
关键词 十二指肠肿瘤/外科学 十二指肠间质瘤 预后 Duodenal Neoplasms/surg Duodenal Gastrointestinal Stromal Tumors Prognosis
  • 相关文献

参考文献20

  • 1Shinomura Y, Kinoshita K, Tsutsui S, et al. Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors[J]. J Gastroenterol, 2005, 40(8):775-780.
  • 2Sakamoto Y, Yamamoto J, Takahashi H, et al. Segmental resection of the third portion of the duodenum for a gastrointestinal stromal tumor: a case report[J]. Jpn J Clin Oncol, 2003, 33(7):364-366.
  • 3Fletcher CD, Berman J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors:a consensus approach[J]. Hum Pathol, 2002, 33(5):459--465.
  • 4Miettinen M, Lasota J. Gastrointestinal stromal tumors--definition, clinical, histological, immunahistochemical, and molecular genetic features and differential diagnosis[J]. Virchows Arch, 2001, 438(1):1-12.
  • 5Kitamura Y. Gastrointestinal slromal tumors: past, present, and future[J]. J Gastroenterol, 2008, 43(7):499-508.
  • 6zynski J, Makhlouf HR, et al. Gastrointestinal tramural leiomyomas, and leiomyosarcomas in clinicopathologic, immunohistochemical, and study of 167 cases[J]. Am J Surg Pathol, 2003, molecular geneti 27(5):625-641. e.
  • 7宁建文,季峰,王丽君,许国强,厉有名.265例胃肠道间叶源性肿瘤的临床病理特征及超声内镜诊断价值[J].中华消化杂志,2006,26(6):381-385. 被引量:37
  • 8Raut CP, DeMatteo RP. Prognostic factors for primary GIST: prime time for personalized therapy?[J]. Ann Surg Oneol, 2008, 15(1):4-6.
  • 9Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines[J]. J Natl Compr Canc Netw, 2004, 2(Suppl 1):S1-29.
  • 10Keun Park C, le E J, Kim M, et al. Prognostic stratification of high- risk gastrointestinal stromal tumors in the era of targeted therapy[J]. Ann Surg, 2008, 247(6):1011-1018.

二级参考文献36

  • 1贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 2詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 3Casali PG, Jost L, Reichardt P, et al. Gatrointestinal stromal tumors: EMSO clinical recommendation for diagnosis, treatment and follow-up[J]. Ann Oncol, 2008, 19(Suppl 2) : 35 -38.
  • 4Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach[ J ]. Hum Pathol, 2002,33(5) :459 -465.
  • 5Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long term follow-up[J]. Am J Surg Pathol, 2005,29( 1 ) :52 -68.
  • 6Miettinen M, Lasota J. KIT (CD117) : a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation [ J ]. Appl hnmunohistochem Mol Morphol, 2005,13 ( 3 ) :205 - 220.
  • 7Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors [ J ]. J Clin Oncol, 2004,22 ( 18 ) : 3813 - 3825.
  • 8Miettinen M, Lasota J. Gastrointestinal stromal tumors : review on morphology, molecular pathology, prognosis, and differential diagnosis[J]. Arch Pathol Lab Med, 2006, 130 (10): 1466 - 1478.
  • 9Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor [ J ]. Hum Pathol, 2008,39 ( 10 ) : 1411 - 1419.
  • 10DeMatteo RK, Owzar KR, Maki R, et al. Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup phase Ⅲ trial ACOSOG Z9001. ASCO Annual Meetings Proceedings Part I [J]. J Clin Oncol, 2007, 25(18Suppl) : 10079.

共引文献119

同被引文献57

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部